Ocugen, Inc. (OCGN)
0.7803
-0.03
(-4.10%)
USD |
NASDAQ |
Oct 16, 16:00
0.7996
+0.02
(+2.47%)
After-Hours: 20:00
Ocugen Net Income (TTM) : -81.81M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -81.81M |
| March 31, 2026 | -71.67M |
| December 31, 2025 | -67.85M |
| September 30, 2025 | -64.02M |
| June 30, 2025 | -56.94M |
| March 31, 2025 | -57.48M |
| December 31, 2024 | -54.05M |
| September 30, 2024 | -51.14M |
| June 30, 2024 | -49.89M |
| March 31, 2024 | -57.68M |
| December 31, 2023 | -63.08M |
| September 30, 2023 | -74.50M |
| June 30, 2023 | -84.71M |
| March 31, 2023 | -81.11M |
| December 31, 2022 | -81.81M |
| September 30, 2022 | -73.99M |
| June 30, 2022 | -62.83M |
| March 31, 2022 | -69.31M |
| December 31, 2021 | -58.36M |
| September 30, 2021 | -47.57M |
| June 30, 2021 | -47.29M |
| March 31, 2021 | -24.96M |
| December 31, 2020 | -21.82M |
| September 30, 2020 | -5.650M |
| June 30, 2020 | -17.95M |
| Date | Value |
|---|---|
| March 31, 2020 | -17.87M |
| December 31, 2019 | -20.24M |
| September 30, 2019 | -38.58M |
| June 30, 2019 | -17.74M |
| March 31, 2019 | -17.98M |
| December 31, 2018 | -26.50M |
| September 30, 2018 | -27.34M |
| June 30, 2018 | -31.40M |
| March 31, 2018 | -34.17M |
| December 31, 2017 | -26.41M |
| September 30, 2017 | -10.56M |
| June 30, 2017 | -13.88M |
| March 31, 2017 | -15.37M |
| December 31, 2016 | -16.21M |
| September 30, 2016 | -33.62M |
| June 30, 2016 | -32.38M |
| March 31, 2016 | -31.98M |
| December 31, 2015 | -32.02M |
| September 30, 2015 | -14.05M |
| June 30, 2015 | -17.95M |
| March 31, 2015 | -22.14M |
| December 31, 2014 | -17.61M |
| September 30, 2014 | -69.91M |
| June 30, 2014 | -62.52M |
| March 31, 2014 | -56.13M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Anika Therapeutics, Inc. | -3.121M |
| Gilead Sciences, Inc. | -3.24B |
| MannKind Corp. | -43.61M |
| Nektar Therapeutics | -157.13M |